Estimating the prevalence of advanced chronic kidney disease in Gard, France
Feasibility Study on Estimating the Prevalence and Management of Stage 4 Chronic Kidney Disease in Adults Via Laboratories and Nephrologists in the Gard, France
This study is trying to see how common advanced chronic kidney disease is in Gard, France, by comparing lab data with patient records to better understand how care is provided.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 3375 (estimated) |
| Sex | All |
| Sponsor | Centre Hospitalier Universitaire de Nīmes Academic / other |
| Locations | 4 sites (Alès and 3 other locations) |
| Trial ID | NCT02938611 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess the feasibility of estimating the prevalence of stage 4 and 5 chronic kidney disease (CKD) in the Gard department of France using data from laboratory databases. It will compare laboratory data with the records of patients who have been seen by nephrologists to determine if the demand for care aligns with nephrology care delivery guidelines set by the French High Authority of Health. The study focuses on understanding the management of advanced CKD in the region.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals diagnosed with stage 4 or 5 chronic kidney disease.
Not a fit: Patients with chronic kidney disease below stage 4 will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve the understanding and management of advanced chronic kidney disease in the Gard region, leading to better patient outcomes.
How similar studies have performed: While this approach is observational and may not have direct precedents, similar studies have successfully utilized laboratory data to estimate disease prevalence in other regions.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * chronic kidney disease (stage \>= 4) Exclusion Criteria: \-
Where this trial is running
Alès and 3 other locations
- AIDER - Unité de Dialyse d'Alès — Alès, France (Recruiting)
- AIDER - Unité de Dialyse de Nîmes, CHU Carémeau — Nîmes, France (Not_yet_recruiting)
- CHU de Nîmes - Hôpital Universitaire Carémeau — Nîmes, France (Not_yet_recruiting)
- Gardialyse — Nîmes, France (Not_yet_recruiting)
Study contacts
- Study coordinator: Olivier Moranne, MD, PhD
- Email: olivier.moranne@chu-nimes.fr
- Phone: +33.(0)4.66.68.31.49
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.